| Financial Year |
March 31 2023 |
| Monetary Funds |
2,287,405,035.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,665,899.54 |
| Accounts Receivable |
971,478,575.82 |
| Advances to Suppliers |
531,289,716.89 |
| Other Receivables |
110,779,358.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
664,858,611.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,706,619.51 |
| Total Current Assets |
6,356,392,567.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
865,399.86 |
| Investment Properties |
93,344,962.49 |
| Fixed Assetes |
137,600,823.88 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,731,688.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
296,717.50 |
| Deferred Income Tax Assets |
34,529,523.54 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
344,444,552.55 |
| Total Assets |
6,700,837,119.89 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,970,000.00 |
| Accounts Payable |
1,471,764,896.24 |
| Accounts Received In Advance |
6,215,113.43 |
| Employee Compensation Payable |
438,354,676.86 |
| Taxes Payable |
11,073,087.52 |
| Interest Payable |
-- |
| Dividend Payable |
1,437,659.15 |
| Other payables |
226,792,502.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,304,863.19 |
| Other Current Liabilities |
169,877,597.40 |
| Sub-Total of Current Liabilities |
3,904,388,627.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,227,381.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,624,036.71 |
| Total Liabilities |
3,920,012,664.05 |
| Paid-In Capital(Or Share Stock) |
593,600,000.00 |
| Capital Surplus |
394,219,809.17 |
| Surplus Reserve |
296,800,000.00 |
| LESS:Treasury Stock |
173,635,841.51 |
| Undistributed Profits |
1,665,284,715.62 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,780,824,455.84 |
| Owner's Equity（Stockholder's Equity） |
2,780,824,455.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,700,837,119.89 |
